Specialist Account Manager

About the role

GSK has an exciting opportunity for an experienced Specialist Account Manager to join our Haematology team. Reporting into the National Sales Manager, you will have full ownership and accountability for managing accounts within your NSW north territory; providing a consistent, science led and value-added service. NSW north territory covers Sydney north, northwest, Central Coast, Newcastle, NSW north coast.

Key responsibilities

• Implementing comprehensive key account plans to drive value and deliver growth
• Clinically differentiate GSK's Haematology portfolio as the preferred option for appropriate patients
• Ensuring that key accounts and stakeholders are engaged, educated and informed to support the patient journey and enhance the quality use of medicines
• Working in partnership with GSK commercial, medical and sales teams to deliver objectives in line with GSK strategic objectives

About you

• Minimum two years' experience in a hospital specialist position is essential, with an applied understanding of the complexities of working in the hospital environment
• Experience with and knowledge of the Haematology therapeutic area would be beneficial, but not essential
• Clear and influential communication skills with the ability to work effectively with both medical and commercial stakeholders
• An aptitude for science, with the ability to relay complex information in a clear and tailored format
• A sharp commercial focus complemented by outstanding account management, influencing and relationship-building skills
• Tenacity, resilience and leadership attributes

Benefits

• A flexible and life-friendly working approach, allowing you to do your best work
• Being part of a supportive organisation that reflects the communities that we work within
• Development and progression at a global scale, with international opportunities
• 5 Feel Good Days and 1 volunteer day (on top of your annual leave)
• Option to purchase up to 4 weeks' additional leave per year

About us

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.